Literature DB >> 31745585

Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study.

Ping Gao1, Xin-Lei Guan2, Rui Huang3, Xiao-Fang Shang-Guan3, Jiang-Wei Luan4, Mao-Chang Liu1, Hua Xu5, Xiao-Wen Wang6.   

Abstract

PURPOSE: Acute nephrotoxicity is a common adverse reaction of tacrolimus therapy; however, its risk factors in pediatric nephrotic syndrome (NS) remain to be evaluated. The objective of this study was to investigate the risk factors and characteristics of tacrolimus-induced acute nephrotoxicity in children with NS.
METHODS: Past records of children with NS admitted to our hospital from 2014 to 2018 were reviewed. The incidence and characteristics of nephrotoxicity were analyzed. Multivariate logistic regression analysis was used to identify the risk factors of nephrotoxicity. A clinically applicable risk score was developed and validated.
RESULTS: Tacrolimus-induced nephrotoxicity occurred in 25 of 129 patients, 13 patients were grade 1, and the renal function was recovered in 22 patients. Multivariate regression analysis showed that the maximum trough concentrations (C12h) of tacrolimus (OR, 1.48; 95% CI, 1.16 to 1.88; P < 0.001), huaiqihuang granules (OR, 0.095; 95% CI, 0.014 to 0.66; P = 0.017), and diarrhea (OR, 22.00; 95% CI, 1.58 to 306.92; P = 0.022) were independently associated with tacrolimus-induced nephrotoxicity. The maximum C12h were significantly higher in patients with nephrotoxicity (median 9.0 ng/ml) and the cut-off value for acute nephrotoxicity was 6.5 ng/ml. The area under the receiver operating characteristic curve was 0.821 for the proposed model based on the observations used to create the model and 0.817 obtained from k-fold cross-validation.
CONCLUSIONS: High trough concentration of tacrolimus and diarrhea can potentiate the risk of tacrolimus-induced acute nephrotoxicity in children with NS, while huaiqihuang granules can protect this condition.

Entities:  

Keywords:  Acute nephrotoxicity; Children; Nephrotic syndrome; Risk factor; Tacrolimus

Year:  2019        PMID: 31745585     DOI: 10.1007/s00228-019-02781-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  34 in total

1.  High Intrapatient Variability of Tacrolimus Exposure in the Early Period After Liver Transplantation Is Associated With Poorer Outcomes.

Authors:  Michel Rayar; Camille Tron; Caroline Jézéquel; Jean Marie Beaurepaire; Antoine Petitcollin; Pauline Houssel-Debry; Christophe Camus; Marie Clémence Verdier; Ammar Dehlawi; Mohamed Lakéhal; Véronique Desfourneaux; Bernard Meunier; Laurent Sulpice; Eric Bellissant; Karim Boudjema; Florian Lemaitre
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

Review 2.  Calcineurin inhibitor nephrotoxicity.

Authors:  Maarten Naesens; Dirk R J Kuypers; Minnie Sarwal
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

3.  Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.

Authors:  Isabel Roberti; Shefali Vyas
Journal:  Pediatr Nephrol       Date:  2010-03-09       Impact factor: 3.714

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome.

Authors:  Afsana Jahan; Ratna Prabha; Swasti Chaturvedi; Binu Mathew; Denise Fleming; Indira Agarwal
Journal:  Pediatr Nephrol       Date:  2015-07-02       Impact factor: 3.714

6.  Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.

Authors:  Lakhmir S Chawla; Rinaldo Bellomo; Azra Bihorac; Stuart L Goldstein; Edward D Siew; Sean M Bagshaw; David Bittleman; Dinna Cruz; Zoltan Endre; Robert L Fitzgerald; Lui Forni; Sandra L Kane-Gill; Eric Hoste; Jay Koyner; Kathleen D Liu; Etienne Macedo; Ravindra Mehta; Patrick Murray; Mitra Nadim; Marlies Ostermann; Paul M Palevsky; Neesh Pannu; Mitchell Rosner; Ron Wald; Alexander Zarbock; Claudio Ronco; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2017-02-27       Impact factor: 28.314

7.  Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study.

Authors:  Jiali Li; Siyang Chen; Xiaoling Qin; Qian Fu; Huichang Bi; Yu Zhang; Xueding Wang; Longshan Liu; Changxi Wang; Min Huang
Journal:  Drug Metab Dispos       Date:  2017-09-01       Impact factor: 3.922

8.  The kallikrein-kinin and renin-angiotensin systems in nephrotic syndrome.

Authors:  A D Cumming; S Jeffrey; A T Lambie; J S Robson
Journal:  Nephron       Date:  1989       Impact factor: 2.847

Review 9.  Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.

Authors:  Tianyi Xia; Sang Zhu; Yan Wen; Shouhong Gao; Mingming Li; Xia Tao; Feng Zhang; Wansheng Chen
Journal:  Drug Des Devel Ther       Date:  2018-02-28       Impact factor: 4.162

10.  Risk Factors for Long-Term Mortality and Progressive Chronic Kidney Disease Associated With Acute Kidney Injury After Cardiac Surgery.

Authors:  Jia-Rui Xu; Jia-Ming Zhu; Jun Jiang; Xiao-Qiang Ding; Yi Fang; Bo Shen; Zhong-Hua Liu; Jian-Zhou Zou; Lan Liu; Chun-Sheng Wang; Claudio Ronco; Hong Liu; Jie Teng
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.